The efficacy and safety of topical polymyxin B, neomycin and gramicidin for treatment of presumed bacterial corneal ulceration

British Journal of Ophthalmology

Volumn 88, Issue 1, 2004, Pages 25-28

  Bosscha, M I ^a   Van Dissel, J T ^a   Kuijper, E J ^a   Swart, W ^a   Jager, M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GRAMICIDIN; NEOMYCIN; POLYMYXIN B; POLYSPECTRAN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CHEMOSIS; CORNEA PERFORATION; CORNEA ULCER; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG PREFERENCE; DRUG SAFETY; DRUG SCREENING; EPITHELIZATION; EVISCERATION; EYE TOXICITY; EYELID EDEMA; FEMALE; FOLLOW UP; HUMAN; HYPEREMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETINA PIGMENT EPITHELIOPATHY; SIDE EFFECT; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; AGED; CORNEAL ULCER; DRUG THERAPY, COMBINATION; EYE INFECTIONS, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; GRAMICIDIN; HUMANS; MALE; MIDDLE AGED; NEOMYCIN; POLYMYXIN B; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0347125031     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.88.1.25     Document Type: Article

References (21)

1. Ostler HB. Disease of the Cornea. In: Mitchell CW, ed. Disease of the external eye and adnexa. Baltimore: Wilkins & Wilkins, 1993:137-252.
2. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology 1981;88:814-20.
3. Allan BD, Dart JK. Strategies for the management of microbial keratitis. Br J Ophthalmol 1995;79:777-86.
4. Jones DB. A plan for antimicrobial therapy in bacterial keratitis. Trans Am Acad Ophthalmol Otolaryngol 1975;79:95-103.
5. Smith A, Pennefather PM, Kaye SB, et al. Fluoroquinolones: place in ocular therapy. Drugs 2001;61:747-61.
6. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 1999;106:1313-18.
7. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000;107:1497-502.
8. Hogan MJ, Kimura SJ, Thygeson P. Signs and symptoms of uveitis. I. Anterior uveitis. Am J Ophthalmol 1959;47:155-70.
9. Murray PR, Baron EJ, Pfaller MA, et al. Manual of Clinical Microbiology, 7 ed. Washington DC: ASM Press, 1999.
10. O'Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol 1995;113:1257-65.
11. Panda A, Ahuja R, Sastry SS. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis. Eye 1999;13(Pt 6):744-7.
12. Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group. Ophthalmology 1996;103:1854-62.
13. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group. Ophthalmology 1997;104:1902-9.
14. Gangopadhyay N, Daniell M, Weih L, et al. Fluoroquinolone and fortified antibiotics for treating bacterial corneal ulcers. Br J Ophthalmol 2000;84:378-84.
15. McLeod SD. The role of cultures in the management of ulcerative keratitis. Cornea 1997;16:381-2.
16. McLeod SD, Kolahdouz-Isfahani A, Rostamian K, et al. The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. Ophthalmology 1996;103:23-8.
17. Levey SB, Katz HR, Abrams DA, et al. The role of cultures in the management of ulcerative keratitis. Cornea 1997;16:383-6.
18. Gritz DC, Whitcher JP Jr. Topical issues in the treatment of bacterial keratitis. Int Ophthalmol Clin 1998;38:107-14.
19. Prajna NV, George C, Selvaraj S, et al. Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis. Cornea 2001;20:175-8.
20. Mallari PL, McCarty DJ, Daniell M, et al. Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol 2001;131:131-3.
21. Morlet N, Minassian D, Butcher J. Risk factors for treatment outcome of suspected microbial keratitis. Ofloxacin Study Group. Br J Ophthalmol 1999;83:1027-31.